UPB - Upstream Bio Corp P/S multiplikatori
Sotuvlarga nisbatan narx koeffitsiyenti aktivning bozor qiymatini aks ettiradi, bunda 54.40 darajasi muhim mezon vazifasini o'taydi. Upstream Bio Inc (UPB) kompaniyasining rivojlanishi test natijalari, tartibga soluvchi organlar qarorlari va investitsiya oqimlariga bog'liq. Kompaniya patent himoyasiga ega bo'lgan maqsadli terapiya ekotizimini yaratayotgan bo'lsa-da, uning respirator patologiyalar uchun yagona dori vositasiga e'tibor qaratgani investorlar uchun sezilarli binary xatarlarni yuzaga keltiradi.
Upstream Bio Corp (UPB) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi statistikasi:
- balans bo'yicha xususiy kapital ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Jamlagan qarzning kapitalga nisbati Upstream Bio Inc|UPB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Upstream Pharma|UPB - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Upstream Bio Corp|UPB - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Upstream Bio|Tezkor likvidlik ko‘rsatkichi upstreambio.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
UPB - Sof daromad|Kutilayotgan sof daromad Upstream Bio Inc|UPB - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Upstream Bio, Inc.|UPB - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Upstream Bio Corp|UPB - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Upstream Bio|UPB - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi upstreambio.com|UPB - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Upstream Bio Inc
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:UPB - upstreambio.com
P/S koeffitsiyenti biznesning bozor qiymatini uning yillik savdo hajmi bilan nisbatda belgilaydi, bu esa investorga kapital qimmat bo'lgan muhitda aktiv uchun haddan tashqari ko'p to'lov darajasini baholash imkonini beradi. Upstream Bio Inc (UPB) kompaniyasi uchun, qayerda samaradorlik biomateriallar uchun sovuq zanjir logistikasining murakkabligiga bog'liq, GURU.Markets platformasidagi P/S vaqtlar ketma-ketligi ushbu infratuzilmaning kengaytirilishi imkoniyatiga va kelgusidagi daromadlar potensialiga bo'lgan bozor ishonchini aks ettiradi.
Raqobatdosh kompaniyalar
ARGX - Sotuvga nisbatan narx|BioNTech - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Abivax Pharma ABVX|ADMA - Narxning daromadga nisbati|Narxning sotuvga nisbati PTGX|Immunovant, Inc. (IMVT) - Narxning daromadga nisbati|KNSA - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati GRFS|ADPT (Adaptive Biotech) - Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati Celldex (CLDX)|AUPH (Aurinia Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCRX (BioCryst)|veratx.com (VERA) - Sotuvga nisbatan narx|Dianthus Therapeutics, Inc. - P/S multiplikatori|PHVS - P/S multiplikatori|AbCellera Biologics Inc (ABCL) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Tourmaline|Kapitalizatsiyaning daromadga nisbati PGEN|PHAR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NKTR|Narxning daromadga nisbati ZBIO (Zenas Bio)|P/S multiplikatori IMNM (Immunome Corp)|Narx/daromad koeffitsiyenti Gossamer Bio Corp. (GOSS)|KALV - Narxning daromadga nisbati|Sotuvga nisbatan narx septerna.com|PVLA (Pieris Pharmaceuticals, Inc.) - Kapitalizatsiyaning daromadga nisbati|Savara Inc - Bozor kapitallashuvining daromadga nisbati|RIGL (Rigel Pharmaceuticals Inc) - P/S multiplikatori|AnaptysBio Inc. (ANAB) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Astria Therapeutics (ATXS)|engene.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori RAPT (RAPT Therapeutics)|JBIO - Kapitalizatsiyaning daromadga nisbati|ACRS: Kapitalizatsiyaning daromadga nisbati|KYTX - P/S multiplikatori|Tiziana Life Sciences (TLSA) - Narxning daromadga nisbati|Narxning sotuvga nisbati CABA (cabalettabio.com)|VTYX (Ventyx Biosciences, Inc.) - P/S multiplikatori|Narxning daromadga nisbati THTX|Narxning daromadga nisbati Avalo Therapeutics Inc. (AVTX)|ELDN: Narxning sotuvga nisbati|P/S multiplikatori AGEN (Agenus)|Bozor kapitallashuvining daromadga nisbati CLYM|Zura Bio - P/S multiplikatori|ATYR - P/S multiplikatori|adagene.com (ADAG) - Narxning daromadga nisbati|Ikena Oncology - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Shattuck Labs Inc|Kapitalizatsiyaning daromadga nisbati Equillium Bio (EQ)|P/S multiplikatori CNTB|P/S multiplikatori immunic-therapeutics.com (IMUX)|Atara Bio - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati IFRX|X4 Pharmaceuticals - P/S multiplikatori|Narx/daromad koeffitsiyenti Adicet Bio ACET|celularity.com (CELU) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati INmune Bio Inc|Narxning daromadga nisbati Barinthus Bio|Kapitalizatsiyaning daromadga nisbati Kezar Life Sciences Inc (KZR)|Kapitalizatsiyaning daromadga nisbati SABS (SAB Biotherapeutics)|P/S multiplikatori akaritx.com (AKTX)|Narxning daromadga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB: Kapitalizatsiya va daromad nisbati|GeoVax Labs Inc - P/S multiplikatori|Sotuvga nisbatan narx Edesa Biotech Corp|IBIO (iBio, Inc.) - Kapitalizatsiyaning daromadga nisbati|Carisma Therapeutics Inc. (CARM) - P/S multiplikatori|Narxning daromadga nisbati XTL Biopharmaceuticals Ltd.|Bolt Bio - Narxning sotuvga nisbati|Narxning daromadga nisbati HCW Biologics Inc. (HCWB)|Narx/daromad koeffitsiyenti aptevotherapeutics.com|AIM ImmunoTech Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati ADTX (Aditxt Inc.)|GRI - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati XRTX (XORTX Therapeutics Inc)|HIND: P/S multiplikatori|Sotuvga nisbatan narx Revelation Biosciences Corp (REVB)|INDP (Indaptus Therapeutics) - P/S multiplikatori|P/S multiplikatori scinai.com|Narxning daromadga nisbati CalciMedica, Inc. (CALI)|Kapitalizatsiyaning daromadga nisbati affimed.com AFMD|Allakos - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati HOOK|IGM Bio - P/S multiplikatori|ITOS: Narxning daromadga nisbati|OCEA: P/S multiplikatori|TCBP - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Third Harmonic Bio, Inc
